Literature DB >> 1833098

Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.

A D Roth1, F J Hornicek, C G Gerstner, J M Kirkwood.   

Abstract

We have studied the influence of tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on the development of cytotoxic T lymphocytes (CTL) against melanoma in mixed lymphocyte tumour cultures (MLTC). In these MLTC, TNF-alpha at 10(4) U/ml increased the expansion of the CTL up to 10(4)-fold over recombinant IL-2 (rIL-2) alone. IFN-gamma at 10(4) U/ml and combinations of TNF-alpha plus IFN-gamma at 10(2)-10(3) U/ml promoted the proliferation more variably. MLTC generated with rIL-2 showed a predominance of CD8+ cells, while 2 weeks of culture in the presence of IFN-gamma at 10(4) U/ml, or with IFN-gamma and TNF alpha at 1 x 10(2)-10(3) U/ml, favoured the emergence of CD4+ cell populations. The cytotoxic activity of the lymphocytes generated in these MLTC showed a consistent decline of K562 cytotoxic activity following exposure to the combination of IFN-gamma and TNF-alpha. Despite the altered T cell subset distribution with different combinations of cytokines, no consistent alteration in the specific anti-tumour cytotoxicity against melanoma was detected. These results suggest that TNF-alpha and IFN-gamma influence the activation, phenotypic, and functional outcome of MLTC-generated CTL, and may account for the phenotypic variations observed in T cell populations generated in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833098      PMCID: PMC1554151          DOI: 10.1111/j.1365-2249.1991.tb05790.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Effects of interferon-gamma on the activation of human T lymphocytes.

Authors:  J P Siegel
Journal:  Cell Immunol       Date:  1988-02       Impact factor: 4.868

2.  Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.

Authors:  Y Takai; S H Herrmann; J L Greenstein; G L Spitalny; S J Burakoff
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

3.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

Authors:  R Philip; L B Epstein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

4.  Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.

Authors:  R J Hackett; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

5.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.

Authors:  D Guerry; M A Alexander; M F Herlyn; L M Zehngebot; K F Mitchell; C M Zmijewski; E J Lusk
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

Authors:  K Itoh; K Shiiba; Y Shimizu; R Suzuki; K Kumagai
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

8.  Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.

Authors:  V Ruggiero; J Tavernier; W Fiers; C Baglioni
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

9.  Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

Authors:  L M Muul; P J Spiess; E P Director; S A Rosenberg
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

10.  Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.

Authors:  S Sone; T Utsugi; A Nii; T Ogura
Journal:  J Natl Cancer Inst       Date:  1988-05-18       Impact factor: 13.506

View more
  3 in total

1.  Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.

Authors:  A D Roth; S Dupuis; P Alberto
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.

Authors:  R E Smith; A M Donachie; F H McLaren; A M Mowat
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

3.  Mathematical modeling of interleukin-27 induction of anti-tumor T cells response.

Authors:  Kang-Ling Liao; Xue-Feng Bai; Avner Friedman
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.